In a report released today, Luke Sergott from Barclays maintained a Hold rating on Certara (CERT – Research Report), with a price target of $11.00. The company’s shares closed yesterday at $9.73.

In a report released on April 4, Michael Cherny from Leerink Partners maintained a Hold rating on Certara (CERT – Research Report), with a price target of $11.50. The company’s shares closed ...

That’s why it’s important to “Look for labels with the NSF or USP certification logos, which indicate that the supplement has undergone an independent review for quality control and consistency.